(third from left) MassBio manager, member recruitment Laura Hamilton; State Senator Richard Ross; State Senator Karen Spilka; Gary Kaufman and Dr. Rafael Nir, managing partners of ABI-LAB; and MLSC vice president for communications and marketing Angus McQuilken (last from right)
Natick, MA – Dr. Michael Kauffman,CEO of Karyopharm Therapeutics Inc., was joined by state officials recently at the grand opening of ABI-LAB, a state-of-the-art 10,000sf differentiated accelerator and bio-incubator in Natick. It provides affordable lab space to seven biotech companies and will be home to over 15 companies as Phase 2 of the building is completed in January 2017.
ABI-LAB offers open-lab and office space for start-up companies. It provides flexible lab space, a collaborative atmosphere, mentoring for start-ups, networking opportunities, and contract lab services, which include protein production, cell-culture, cell-based assays, biomarker analysis, and animal studies (oncology and NASH models).
ABI-LAB is planning to expand and add eight additional suites, lab and office space by January 2017.
